MSB 3.76% $1.03 mesoblast limited

aust. fourth largest biotech company

  1. 5,344 Posts.
    lightbulb Created with Sketch. 955
    With MSB,s Acquisition of U.S.A based Angioblast systems, makes MSB The world?s largest Stem cell company, and the fourth largest Australian biotech company, behind Majors CSL, Cochlear and ResMed. Its interesting to note the first mentioned two are at $32 and $69 respectively.(and incidently they retracted over the last five trading days. MSB advanced 2% over the same period)Then again they are making big profits our turn is coming. So my envision is to see MSB,s share price value to be sitting somewhere between the two majors within 5 years, and i believe that is being conserative .Cheers holders .... and we are growing .....
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.03
Change
-0.040(3.76%)
Mkt cap ! $1.170B
Open High Low Value Volume
$1.07 $1.07 $1.01 $13.19M 12.81M

Buyers (Bids)

No. Vol. Price($)
3 61090 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 239558 5
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.